Cardiopulmonary Adverse Events of Remimazolam versus Propofol During Cervical Conization: A Randomized Controlled Trial
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s405057 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Lini Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China. Hauptthemen laut MEDLINE: Propofol, Hypotension. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, People's Republic of China.
Zitieren
APA
Wang, L., Wang, Y., Ma, L., Wang, Y., Mu, X., Huang, Z., Zheng, Z., & Nie, H. (2023). Cardiopulmonary Adverse Events of Remimazolam versus Propofol During Cervical Conization: A Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s405057
Vancouver
Wang L, Wang Y, Ma L, Wang Y, Mu X, Huang Z, et al. Cardiopulmonary Adverse Events of Remimazolam versus Propofol During Cervical Conization: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s405057
BibTeX
@article{Wang2023,
author = {Wang, Lini and Wang, Yi and Ma, Li and Wang, Yiting and Mu, Xiaoxiao and Huang, Zhaoxu and Zheng, Ziyu and Nie, Huang},
title = {Cardiopulmonary Adverse Events of Remimazolam versus Propofol During Cervical Conization: A Randomized Controlled Trial},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s405057}
}
EUVIMED